After the pharmaceutical industry’s muted mergers and acquisitions (M&A) landscape in 2024, Nick Petschek, EMEA MD at Kotter International suggests many expect M&A to pick back up in 2025.
Lifebit has announced a partnership with Troper Wojcicki Philanthropies (TWP), which deploys philanthropy and mission-related investments in key priority areas including accelerating cancer research.
Clinigen, the global speciality pharmaceutical services group, and Essential Pharma, an international specialty pharmaceutical group, has announced an expansion of their JAPAC collaboration.
Uniphar is expanding its international presence with the launch of three new facilities located in Raleigh, USA, Lelystad, Netherlands, and Dublin, Ireland.
Recipharm has announced that a new modular sterile filling system specifically tailored for process development, pilot scale and clinical supply, is now fully operational at its state-of-the-art facility in Wasserburg, Germany.
